Back
' Control Over at Stake as RBI Mandates Listing, Dispute Escalates
The ongoing corporate governance battle between the and has entered a critical phase, exposing a fundamental tension between philanthropic control and regulatory compliance. While public attention has focused on the reappointment of Chairman N Chandrasekaran, a deeper structural crisis looms: the 's rejection of ' application to surrender its registration has made a stock market listing all but inevitable. For the , which collectively own approximately 66% of , this development threatens to unravel the very mechanism through which they have exercised control for decades—and with it, the steady dividend stream that funds hospitals, schools, and scholarships across India.
The Deadlock
The immediate trigger for the current impasse was the annual general meeting on , which had to be adjourned for want of . The company’s articles require a representative jointly nominated by the and the —which together hold about 52% of the shares—to be present. However, the is currently restrained from holding trustee meetings while proceedings before the continue. Without a trustee meeting, no nomination could be made, and without that nomination, the AGM lacked the required .
The deadline for holding the AGM has since been extended to December, but the underlying problem remains: the controlling shareholder—the —cannot exercise the control its shareholding appears to confer. This structural weakness is not merely procedural; it reflects a governance architecture that was built for consensus but is now tested by .
The Dispute
The most publicly visible legal battle concerns the reappointment of N Chandrasekaran as Chairman of . On , Chandrasekaran informed the board that he would not seek a third term. On , the RBI rejected the company's application to surrender its CIC registration. On , the board reappointed him for five years by a vote of four to one, with Noel Tata dissenting.
The argue that of ’ articles requires the of a majority of the two appointed by the Trusts. Since a majority of two is two, and Noel Tata voted against, the resolution is void. counters that the board vote of 4-1 is valid under the articles. The same interpretative dispute may also affect the board’s decision to initiate steps toward compliance with the RBI framework.
While the chairmanship question is significant—whoever holds the office will engage with the RBI, shape the listing process, and choose advisers—it is, as one legal commentator observed,
"an instrument, not the outcome."
Even if the Trusts win completely on
, the regulatory reality remains unchanged.
RBI's Mandate and the Inevitability of Listing
The RBI’s rejection of ' application to exit the CIC framework is the single most consequential development. is classified as an under the 's . Unless the company succeeds in court or persuades the RBI to accept an alternative compliance route, listing is now the default regulatory outcome.
"The Trusts may win the argument over who holds the wheel without deciding where the company must go,"
wrote the advocate. A shareholder, however large, cannot outvote the central bank. The Trusts have recorded their desire to keep
unlisted in a resolution passed last year, but 66% of the equity cannot override a
.
Listing would not automatically extinguish the that the enjoy under the company's articles—such as the power to nominate directors and veto certain decisions. However, it would fundamentally alter the legal framework governing those rights. Regulation 31B of the ( and ) Regulations requires that any granted to shareholders be approved by a of public shareholders every five years. would therefore cease to be a protection secured solely within the company’s private contractual documents; it would become a protection that must periodically be justified to minority investors.
The Real Stake: Control vs. Value for Charitable Beneficiaries
The are not ordinary shareholders. They are public charitable trusts that hold their shares in for the benefit of the public, not for private profit. The dividend stream from —which in a recent year amounted to approximately ₹1,731 crore—supports a wide array of philanthropic activities. The case for keeping unlisted is rooted in preserving control, which in turn protects that dividend stream. The case for listing is rooted in unlocking value, which could permanently enlarge the Trusts' corpus.
When control and value point in opposite directions, which duty prevails? That question belongs to the Charity Commissioner, not to the , and it is far more uncomfortable for the Trusts than any dispute over . Trustees owe a to their beneficiaries. If listing would increase the corpus and thereby expand the Trusts' capacity to fund charitable activities, can the trustees legitimately oppose it solely to preserve their own control?
This is not a hypothetical question. The deadlock between the Trusts and the
board has already exposed a fundamental governance flaw. Under Ratan Tata, the same person chaired both the Trusts and the company. The separation of those offices made sense from a governance perspective—philanthropy and business should not depend on one individual—but it removed a common centre without creating a mechanism to resolve
. As the advocate noted,
"Goodwill was doing work that machinery should have done. The articles explain precisely how a decision can be stopped, but much less clearly how an
must end."
The Path Forward: Negotiation Over Litigation
For the legal community, the dispute offers a rich case study in the intersection of corporate law, charitable trust law, and financial regulation. The immediate question—whether requires a unanimous vote of the Trusts' —will likely be resolved by the NCLT or the courts. But the larger contest is about the terms on which the will relinquish or adapt their control.
The Trusts have substantial leverage. They own 66% of the shares. They can shape the timing and extent of any dilution, the survival of nominee and reserved-matter rights, and the dividend policy. They can also insist on a that does not again leave a 66% shareholder unable to act. But that leverage is finite and time-sensitive. Every month spent litigating the chairmanship is a month lost in negotiating the post-listing governance structure.
"
once went to the
to preserve these protections for the Trusts,"
the advocate reminded.
"It would be a poor outcome if the Trusts spent their leverage on a chairmanship at the precise moment they needed it for something considerably larger."
The real bargain concerns the regulatory timeline, the extent of dilution, and the continued validity of under the framework. Those questions remain open. The Trusts can still shape their answers—but only if they stop treating the chairmanship as the destination and start using the contest as leverage in a larger negotiation that will determine the future of one of India's most iconic business groups and the charitable ecosystem it sustains.
